UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 428

Sortiert nach

Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

Journal of medicinal chemistry, 2006-12, Vol.49 (26), p.7584-7587

2006

Volltextzugriff (PDF)

The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization

Bioorganic & medicinal chemistry, 2012-05, Vol.20 (9), p.2845-2849

2012

Volltextzugriff (PDF)

Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity

ACS medicinal chemistry letters, 2012-03, Vol.3 (3), p.252-256

2012

Volltextzugriff (PDF)

Addressing the metabolic activation potential of new leads in drug discovery: a case study using ion trap mass spectrometry and tritium labeling techniques

Journal of mass spectrometry., 2003-02, Vol.38 (2), p.211-221

2003

Volltextzugriff (PDF)

Discovery of Benzodiazepine Sulfonamide-Based Bombesin Receptor Subtype 3 Agonists and Their Unusual Chirality

ACS medicinal chemistry letters, 2011-12, Vol.2 (12), p.933-937

2011

Volltextzugriff (PDF)

Synthesis and cannabinoid-1 receptor binding affinity of conformationally constrained analogs of taranabant

Bioorganic & medicinal chemistry letters, 2010-08, Vol.20 (16), p.4757-4761

2010

Volltextzugriff (PDF)

Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists

Bioorganic & medicinal chemistry letters, 2007-04, Vol.17 (8), p.2184-2187

2007

Volltextzugriff (PDF)

Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4

Bioorganic & medicinal chemistry letters, 2004-05, Vol.14 (9), p.2331-2334

2004

Volltextzugriff (PDF)

Effects of mutations at conserved TM II residues on ligand binding and activation of mouse 5-HT6 receptor

European journal of pharmacology, 2006-03, Vol.534 (1-3), p.77-82

2006

Volltextzugriff (PDF)

N-Aryl-prolyl-dipeptides as potent antagonists of VLA-4

Bioorganic & medicinal chemistry letters, 2002-08, Vol.12 (16), p.2205-2208

2002

Volltextzugriff (PDF)

N-(Arylacetyl)-biphenylalanines as Potent VLA-4 Antagonists

Bioorganic & medicinal chemistry letters, 2002-08, Vol.12 (16), p.2141-2144

2002

Volltextzugriff (PDF)

Specific and dual antagonists of α4β1 and α4β7 integrins

Bioorganic & medicinal chemistry letters, 2002-01, Vol.12 (2), p.133-136

2002

Volltextzugriff (PDF)

Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonists

Bioorganic & medicinal chemistry letters, 2002-09, Vol.12 (17), p.2415-2418

2002

Volltextzugriff (PDF)

The Discovery of acylated β-Amino acids as potent and orally bioavailable VLA-4 antagonists

Bioorganic & medicinal chemistry letters, 2002-02, Vol.12 (4), p.611-614

2002

Volltextzugriff (PDF)

Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents

The Journal of pharmacology and experimental therapeutics, 2007-06, Vol.321 (3), p.1013

2007

Volltextzugriff (PDF)

Specific and dual antagonists of alpha(4)beta(1) and alpha(4)beta(7) integrins

Bioorganic & medicinal chemistry letters, 2002-01, Vol.12 (2), p.133-136

2002

Volltextzugriff (PDF)

Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides

Journal of medicinal chemistry, 1993-12, Vol.36 (26), p.4293-4301

1993

Volltextzugriff (PDF)

Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments

American journal of physiology: endocrinology and metabolism, 2010-11, Vol.299 (5), p.E816-E824

2010

Volltextzugriff (PDF)

Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding

Journal of medicinal chemistry, 1992-01, Vol.35 (2), p.252-258

1992

Volltextzugriff (PDF)

Essentials of stem cell biology

Lanza, R. P. (Robert Paul)

2nd ed., 2009

Volltextzugriff (PDF)

Discovery of N-{N-[(3-Cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(l)-prolyl}-4-[(3′,5′-dichloroisonicotinoyl)amino]-(l)-phenylalanine (MK-0668), an Extremely Potent and Orally Active Antagonist of Very Late Antigen-4

Journal of medicinal chemistry, 2009-06, Vol.52 (11), p.3449-3452

2009

Volltextzugriff (PDF)

Counterterrorist Detection Techniques of Explosives

Yinon, Jehuda

1, 2011

Volltextzugriff (PDF)

Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments

American journal of physiology: endocrinology and metabolism, 2010, Vol.62 (5)

2010

Volltextzugriff (PDF)

1 – 25 von 428

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(321)
Mit Volltextzugriff
(369)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(172)
Life Sciences & Biomedicine
(104)
Humans
(69)
Physical Sciences
(52)
Animals
(44)
Biological And Medical Sciences
(43)
Medical Sciences
(41)
Nuclear Physics And Radiation Physics
(41)
Male
(40)
Physics
(38)
Female
(31)
Pharmacology & Pharmacy
(30)
Technology
(25)
Chemistry, Medicinal
(24)
Pharmacology. Drug Treatments
(24)
Chemistry
(23)
Mice
(22)
Science & Technology - Other Topics
(21)
Middle Aged
(18)
Aged
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization

Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity

Addressing the metabolic activation potential of new leads in drug discovery: a case study using ion trap mass spectrometry and tritium labeling techniques

Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain

Discovery of Benzodiazepine Sulfonamide-Based Bombesin Receptor Subtype 3 Agonists and Their Unusual Chirality

Discovery of N-{(1S,2S)-2-(3-Cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a Cannabinoid-1 Receptor Positron Emission Tomography Tracer Suitable for Clinical Use

Synthesis and cannabinoid-1 receptor binding affinity of conformationally constrained analogs of taranabant

Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists

Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4

Effects of mutations at conserved TM II residues on ligand binding and activation of mouse 5-HT6 receptor

N-Aryl-prolyl-dipeptides as potent antagonists of VLA-4

N-(Arylacetyl)-biphenylalanines as Potent VLA-4 Antagonists

Specific and dual antagonists of α4β1 and α4β7 integrins

Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonists

The Discovery of acylated β-Amino acids as potent and orally bioavailable VLA-4 antagonists

Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents

Specific and dual antagonists of alpha(4)beta(1) and alpha(4)beta(7) integrins

Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides

Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments

Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding

Essentials of stem cell biology

Discovery of N-{N-[(3-Cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(l)-prolyl}-4-[(3′,5′-dichloroisonicotinoyl)amino]-(l)-phenylalanine (MK-0668), an Extremely Potent and Orally Active Antagonist of Very Late Antigen-4

Counterterrorist Detection Techniques of Explosives

Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments

Suchergebnisse filtern